Marco Wiltgen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marco Wiltgen has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Gernot P. Tilz
Medical University of Graz
4 shared publicationsA. Gerger
Department of Internal Medicine, Division of Oncology, Medical University of Graz, Graz, Austria
1 shared publication- Armin Gerger
Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria
1 shared publication C. Wagner
Institute of Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria
1 shared publicationChristian Wagner
1 shared publication- Gernot P. Tilz
Medical University of Graz, Graz, Austria
1 shared publication
Latest Publications
- 16 December 2009
- Published by S. Karger AG in International Archives of Allergy and Immunology
- Vol. 152 (2) , 184-194
The Diabetic Antigen Glutamic Acid Decarboxylase (GAD 65) in the Human Peripheral Blood
Background: Glutamic acid decarboxylase (GAD 65) is a diabetes-associated antigen which is generally considered to be strictly intracellular. In order to better understand autoimmunity, this study demonstrates the appearance of GAD 65 in the peripheral human blood and presents implications for the diagnosis and therapy of some autoimmune diseases. Methods: The GAD 65 molecules are detected by their interaction with monoclonal antibodies labeled with dyes in an experimental setup with fluorescence correlation spectroscopy (FCS). These interactions result in changes in Brownian motion measured as fluorescence fluctuations. Sera from 153 patients with diabetes mellitus type 1 and controls were investigated. To enable the representation of the molecule as a model for further discussions, we present structural visualizations of its hydrophobic properties, leading to possible interactions with the cell membrane lipids and epitope locations. Results: The GAD65 antigen could be measured with a sensitivity of 2.65 µg/ml in ‘clean systems’ resulting from spiking experiments and human sera. The GAD 65 antigen could be identified in 8 patient sera: 4 children with diabetes mellitus type 1 and 4 adults initially taken as controls but who retrospectively showed signs of autoimmunity. Conclusion: We conclude that these findings are of significance for the concept of autoimmunity, i.e. in an initial step the immune system is primed by its accessibility to GAD 65. Our experimental results may also be important for the therapy of diabetes mellitus type 1 and other autoimmune diseases by the passive administration of GAD 65 antibodies.
- 16 December 2009
- Published by S. Karger AG in International Archives of Allergy and Immunology
- Vol. 152 (2) , 184-194
The Diabetic Antigen Glutamic Acid Decarboxylase (GAD 65) in the Human Peripheral Blood
Background: Glutamic acid decarboxylase (GAD 65) is a diabetes-associated antigen which is generally considered to be strictly intracellular. In order to better understand autoimmunity, this study demonstrates the appearance of GAD 65 in the peripheral human blood and presents implications for the diagnosis and therapy of some autoimmune diseases. Methods: The GAD 65 molecules are detected by their interaction with monoclonal antibodies labeled with dyes in an experimental setup with fluorescence correlation spectroscopy (FCS). These interactions result in changes in Brownian motion measured as fluorescence fluctuations. Sera from 153 patients with diabetes mellitus type 1 and controls were investigated. To enable the representation of the molecule as a model for further discussions, we present structural visualizations of its hydrophobic properties, leading to possible interactions with the cell membrane lipids and epitope locations. Results: The GAD65 antigen could be measured with a sensitivity of 2.65 µg/ml in ‘clean systems’ resulting from spiking experiments and human sera. The GAD 65 antigen could be identified in 8 patient sera: 4 children with diabetes mellitus type 1 and 4 adults initially taken as controls but who retrospectively showed signs of autoimmunity. Conclusion: We conclude that these findings are of significance for the concept of autoimmunity, i.e. in an initial step the immune system is primed by its accessibility to GAD 65. Our experimental results may also be important for the therapy of diabetes mellitus type 1 and other autoimmune diseases by the passive administration of GAD 65 antibodies.
- 1 March 2009
- Published by Springer Nature in Wiener Medizinische Wochenschrift
- Vol. 159 (5-6) , 112-125
Homology Modelling: Eine Übersicht über die Methode am Beispiel der Strukturbestimmung vom Diabetes Antigen GAD 65
Dieser Übersichtsartikel behandelt die Grundlagen und klinische Anwendungen der Protein-Strukturvorhersage mit der "Homology Modelling"-Methode. Der Artikel richtet sich vornehmlich an Mediziner und medizinische Chemiker. Da viele Proteine unmittelbar von klinischer Bedeutung sind, ist die Strukturbestimmung entscheidend für das Verständnis der molekularen Grundlage von Stoffwechsel, Signalübertragung, Immunreaktionen und damit assoziierten Krankheiten. "Homology Modelling" beruht auf dem Prinzip, dass Proteine mit ähnlichen Sequenzen hohe Strukturübereinstimmungen aufweisen. Dabei werden Informationen, wie Atomabstände, Bindungslängen, Bindungswinkel etc., über bereits bekannten Strukturen verwendet, um die unbekannte Proteinstruktur anhand ihrer Sequenz vorauszusagen. Da in Zukunft für jede Proteinfamilie mindestens ein Mitglied mit bekannter Struktur verfügbar sein wird, ist zu erwarten, dass Bedeutung und Anwendbarkeit der "Homology Modelling"-Methode weiter zunehmen werden. In dieser Arbeit werden die Grundlagen der Methode anhand der Strukturvorhersage des Enzyms Glutamate Decarboxylase (GAD 65) erläutert. GAD 65 spielt als Antigen bei Diabetes Mellitus Typ 1 eine entscheidende Rolle. This introductory paper describes the basic principles and clinical applications of the protein 3D structure prediction by homology modelling. The paper mainly addresses physicians and medical chemists. Because many proteins are of immediate clinical importance, the determination of their structures is crucial for molecular medicine. In homology modelling, a protein sequence with unknown structure is aligned with sequences of known protein structures. By exploiting structural information from the known configurations, the new structure can be predicted. The necessary condition for successful homology modelling is a sufficient similarity between the protein sequences. Because in the near future for every protein family at least one member with a known structure will be available, the importance and applicability of homology modelling is steadily increasing. We demonstrate the principles of homology modelling on hand of the Glutamic Acid Decarboxylase (GAD 65) structure prediction, which is a typical autoantigen involved in Diabetes Mellitus Type 1.
- 1 March 2009
- Published by Springer Nature in Wiener Medizinische Wochenschrift
- Vol. 159 (5-6) , 112-125
Homology Modelling: Eine Übersicht über die Methode am Beispiel der Strukturbestimmung vom Diabetes Antigen GAD 65
Dieser Übersichtsartikel behandelt die Grundlagen und klinische Anwendungen der Protein-Strukturvorhersage mit der "Homology Modelling"-Methode. Der Artikel richtet sich vornehmlich an Mediziner und medizinische Chemiker. Da viele Proteine unmittelbar von klinischer Bedeutung sind, ist die Strukturbestimmung entscheidend für das Verständnis der molekularen Grundlage von Stoffwechsel, Signalübertragung, Immunreaktionen und damit assoziierten Krankheiten. "Homology Modelling" beruht auf dem Prinzip, dass Proteine mit ähnlichen Sequenzen hohe Strukturübereinstimmungen aufweisen. Dabei werden Informationen, wie Atomabstände, Bindungslängen, Bindungswinkel etc., über bereits bekannten Strukturen verwendet, um die unbekannte Proteinstruktur anhand ihrer Sequenz vorauszusagen. Da in Zukunft für jede Proteinfamilie mindestens ein Mitglied mit bekannter Struktur verfügbar sein wird, ist zu erwarten, dass Bedeutung und Anwendbarkeit der "Homology Modelling"-Methode weiter zunehmen werden. In dieser Arbeit werden die Grundlagen der Methode anhand der Strukturvorhersage des Enzyms Glutamate Decarboxylase (GAD 65) erläutert. GAD 65 spielt als Antigen bei Diabetes Mellitus Typ 1 eine entscheidende Rolle. This introductory paper describes the basic principles and clinical applications of the protein 3D structure prediction by homology modelling. The paper mainly addresses physicians and medical chemists. Because many proteins are of immediate clinical importance, the determination of their structures is crucial for molecular medicine. In homology modelling, a protein sequence with unknown structure is aligned with sequences of known protein structures. By exploiting structural information from the known configurations, the new structure can be predicted. The necessary condition for successful homology modelling is a sufficient similarity between the protein sequences. Because in the near future for every protein family at least one member with a known structure will be available, the importance and applicability of homology modelling is steadily increasing. We demonstrate the principles of homology modelling on hand of the Glutamic Acid Decarboxylase (GAD 65) structure prediction, which is a typical autoantigen involved in Diabetes Mellitus Type 1.
- 1 January 2009
- Published by Bentham Science Publishers Ltd. in Current Bioinformatics
- Vol. 4 (1) , 54-87
Structural Bioinformatics: From the Sequence to Structure and Function
Proteins are the molecules of life which are involved in cellular processes. The functional specificity of a protein is linked to its structure. A great section of bioinformatics deals with the prediction, analysis and visualization of protein 3D structures. High-throughput methods for the determination of protein structures provide the information needed to build structure-activity relationships. The accessibility of these structural data together with genomic and clinical data is of crucial importance for the application of bioinformatics in medical research. The experimental methods are supplemented by homology modelling, where new protein structures are predicted by exploiting structural information from known configurations. Computer visualization of protein models provide insights into biological processes which can not be adequately explained otherwise. For the analysis of protein-protein interactions, Voronoi tessellations are used to quantify the macromolecular interfaces. Details at the atomic and electronic levels of the protein molecules, needed for a deeper understanding of properties that remain unrevealed after structural elucidation, are provided by methods based on quantum theoretical calculations. Many proteins are of immediate medical and pharmacological relevance. The structural analysis is therefore of special interest to understand diseases at a molecular level, which is the prerequisite for new developments in diagnosis and therapy.
- 1 January 2009
- Published by Bentham Science Publishers Ltd. in Current Bioinformatics
- Vol. 4 (1) , 54-87
Structural Bioinformatics: From the Sequence to Structure and Function
Proteins are the molecules of life which are involved in cellular processes. The functional specificity of a protein is linked to its structure. A great section of bioinformatics deals with the prediction, analysis and visualization of protein 3D structures. High-throughput methods for the determination of protein structures provide the information needed to build structure-activity relationships. The accessibility of these structural data together with genomic and clinical data is of crucial importance for the application of bioinformatics in medical research. The experimental methods are supplemented by homology modelling, where new protein structures are predicted by exploiting structural information from known configurations. Computer visualization of protein models provide insights into biological processes which can not be adequately explained otherwise. For the analysis of protein-protein interactions, Voronoi tessellations are used to quantify the macromolecular interfaces. Details at the atomic and electronic levels of the protein molecules, needed for a deeper understanding of properties that remain unrevealed after structural elucidation, are provided by methods based on quantum theoretical calculations. Many proteins are of immediate medical and pharmacological relevance. The structural analysis is therefore of special interest to understand diseases at a molecular level, which is the prerequisite for new developments in diagnosis and therapy.
- 1 August 2008
- Published by Taylor & Francis in Hematology
- Vol. 13 (4) , 224-229
Tumour necrosis factor and its receptor: a basic structural analysis of two counterparts
Inflammation of vessels is partially caused by tumour necrosis factor (TNF). Although the pharmacological understanding of the main inflammatory protein data is well characterised, basic structural information is rare. For this reason, we developed a method for the representation and analysis of the macromolecular interface between TNF and its receptor, enabling a better understanding of their interaction. In this paper we use structural information on the TNF-receptor complex in the protein (PDB) database as input to calculate an interface contact matrix, based on the distance between individual residues of each counterpart. The two-dimensional matrix is a plot of pairwise interactions between adjacent residues of the two chains in the protein complex. The residue names within each chain are plotted on the respective axis and an entry is made wherever two residues come into close contact. The matrix elements are annotated with physicochemical properties. The interface contact matrix is linked to a 3D visualisation of the macromolecular structure in such a way that mouse clicking on the appropriate part of the interface contact matrix highlights the corresponding residues in the 3D structure. Additionally the residues in the matrix are used to define the molecular surface at the interface. The interface contact matrix enables an overview representation of the residue distribution at the macromolecular interface and an evaluation of interfacial 'hot spots'. The selection of the residues in the interface contact matrix and the highlighting in the 3D structure allow an easy retrieval of the desired information out of the wealth of structural information. The representation with molecular surfaces shows complementary shapes. Many forms of treatment have been developed to reduce excessive TNF activity and their success is based on knowledge of the active sites of TNF. Our macromolecular interface analysis system will help us to define better receptor and acceptor molecules for the neutralisation and excretion of TNF.
- 1 August 2008
- Published by Taylor & Francis in Hematology
- Vol. 13 (4) , 224-229
Tumour necrosis factor and its receptor: a basic structural analysis of two counterparts
Inflammation of vessels is partially caused by tumour necrosis factor (TNF). Although the pharmacological understanding of the main inflammatory protein data is well characterised, basic structural information is rare. For this reason, we developed a method for the representation and analysis of the macromolecular interface between TNF and its receptor, enabling a better understanding of their interaction. In this paper we use structural information on the TNF-receptor complex in the protein (PDB) database as input to calculate an interface contact matrix, based on the distance between individual residues of each counterpart. The two-dimensional matrix is a plot of pairwise interactions between adjacent residues of the two chains in the protein complex. The residue names within each chain are plotted on the respective axis and an entry is made wherever two residues come into close contact. The matrix elements are annotated with physicochemical properties. The interface contact matrix is linked to a 3D visualisation of the macromolecular structure in such a way that mouse clicking on the appropriate part of the interface contact matrix highlights the corresponding residues in the 3D structure. Additionally the residues in the matrix are used to define the molecular surface at the interface. The interface contact matrix enables an overview representation of the residue distribution at the macromolecular interface and an evaluation of interfacial 'hot spots'. The selection of the residues in the interface contact matrix and the highlighting in the 3D structure allow an easy retrieval of the desired information out of the wealth of structural information. The representation with molecular surfaces shows complementary shapes. Many forms of treatment have been developed to reduce excessive TNF activity and their success is based on knowledge of the active sites of TNF. Our macromolecular interface analysis system will help us to define better receptor and acceptor molecules for the neutralisation and excretion of TNF.
- 1 January 2008
- Published by Georg Thieme Verlag KG in Methods of Information in Medicine
- Vol. 47 (01) , 14-25
Automatic Identification of Diagnostic Significant Regions in Confocal Laser Scanning Microscopy of Melanocytic Skin Tumors
Objectives: Confocal laser scanning microscopy (CLSM) is used for quick medical checkups. The aim of this study is to check the discrimination power of texture features for the automatic identification of diagnostic significant regions in CLSM views of skin lesions. Methods: In tissue counter analysis (TCA) the images are dissected in equal square elements, where different classes of features are calculated out. Features defined in the spatial domain are based on histogram (grey level distribution) and co-occurrence matrix (grey level combinations). The features defined in the frequency domain are based on spectral properties of the wavelet Daubechie 4 transform (texture exploration at different scales) and the Fourier transform (global texture properties are localized in the spectrum). Hundred cases of benign common nevi and malignant melanoma were used as the study set. Classification was done with CART (Classification and Regression Trees) analysis which splits the set of square elements into homogenous terminal nodes and generates a set of splitting rules. Results: Features based on the wavelet transform provide the best results with 96.0% of correctly classified elements from benign common nevi and 97.0% from malignant melanoma. The classification results are relocated to the images by use of the splitting rules as diagnostic aid. The discriminated square elements are highlighted in the images, showing tissue with features in good accordance with typical diagnostic CLSM features. Conclusion: Square elements with more than 80% of discrimination power enable the identification of diagnostic highly significant parts in confocal microscopic views of malignant melanoma.
- 1 January 2008
- Published by Georg Thieme Verlag KG in Methods of Information in Medicine
- Vol. 47 (01) , 14-25
Automatic Identification of Diagnostic Significant Regions in Confocal Laser Scanning Microscopy of Melanocytic Skin Tumors
Objectives: Confocal laser scanning microscopy (CLSM) is used for quick medical checkups. The aim of this study is to check the discrimination power of texture features for the automatic identification of diagnostic significant regions in CLSM views of skin lesions. Methods: In tissue counter analysis (TCA) the images are dissected in equal square elements, where different classes of features are calculated out. Features defined in the spatial domain are based on histogram (grey level distribution) and co-occurrence matrix (grey level combinations). The features defined in the frequency domain are based on spectral properties of the wavelet Daubechie 4 transform (texture exploration at different scales) and the Fourier transform (global texture properties are localized in the spectrum). Hundred cases of benign common nevi and malignant melanoma were used as the study set. Classification was done with CART (Classification and Regression Trees) analysis which splits the set of square elements into homogenous terminal nodes and generates a set of splitting rules. Results: Features based on the wavelet transform provide the best results with 96.0% of correctly classified elements from benign common nevi and 97.0% from malignant melanoma. The classification results are relocated to the images by use of the splitting rules as diagnostic aid. The discriminated square elements are highlighted in the images, showing tissue with features in good accordance with typical diagnostic CLSM features. Conclusion: Square elements with more than 80% of discrimination power enable the identification of diagnostic highly significant parts in confocal microscopic views of malignant melanoma.
- 1 August 2007
- Vol. 29 (4)
Evaluation of texture features in spatial and frequency domain for automatic discrimination of histologic tissue.
To investigate the applicability of different texture features in automatic discrimination of microscopic views from benign common nevi and malignant melanoma lesions.
- 1 August 2007
- Vol. 29 (4)
Evaluation of texture features in spatial and frequency domain for automatic discrimination of histologic tissue.
To investigate the applicability of different texture features in automatic discrimination of microscopic views from benign common nevi and malignant melanoma lesions.
- 1 August 2007
- Published by Taylor & Francis in Hematology
- Vol. 12 (4) , 271-287
DNA microarray analysis: Principles and clinical impact
In recent years, a new technology, allowing the measurements of the expression of thousands of genes simultaneously, has emerged in medicine. This method, called DNA microarray analysis, is today one of the most promising method in functional genomics. Fundamental patterns in gene expression are extracted by several clustering methods like: hierarchical clustering, self organizing maps and support vector machines. Changes in gene expression, as a response to changing environment conditions, diseases, drug treatment or chemotherapy medications, can be detected allowing insights into the dynamic of the genome. Microarrays seem to be an important tool for diagnosis of diseases at a molecular level. Applications are for example the improvement of diagnosis and treatment of cancer and the improvement of the effectiveness of drug treatment. In this introductory paper, we present the principles of DNA microarray experiments, selected clustering methods for gene expression analysis and the impact to clinical research.
- 1 August 2007
- Published by Taylor & Francis in Hematology
- Vol. 12 (4) , 271-287
DNA microarray analysis: Principles and clinical impact
In recent years, a new technology, allowing the measurements of the expression of thousands of genes simultaneously, has emerged in medicine. This method, called DNA microarray analysis, is today one of the most promising method in functional genomics. Fundamental patterns in gene expression are extracted by several clustering methods like: hierarchical clustering, self organizing maps and support vector machines. Changes in gene expression, as a response to changing environment conditions, diseases, drug treatment or chemotherapy medications, can be detected allowing insights into the dynamic of the genome. Microarrays seem to be an important tool for diagnosis of diseases at a molecular level. Applications are for example the improvement of diagnosis and treatment of cancer and the improvement of the effectiveness of drug treatment. In this introductory paper, we present the principles of DNA microarray experiments, selected clustering methods for gene expression analysis and the impact to clinical research.
- Open Access
- 1 February 2007
- Published by Walter de Gruyter GmbH in Pteridines
- Vol. 18 (1) , 79-94
A Basic Molecular Analysis of the Diabetic Antigen GAD by Homology Modelling. Principles of the Method and Understanding of Antigenicity and Binding Sites
Functional specificity of a protein is linked to its structure. A growing section of bioinformatics deals with the prediction and visualization of protein 3D structures. In homology modelling, a protein sequence with an unknown structure is aligned with sequences of known protein structures. By exploiting structural information from the known configurations, the new structure can be predicted. In this introductory paper, we will present the principles of homology modelling and demonstrate the method used, by determining the structure of the enzyme glutamic decarboxylase (GAD 65). This protein is an autoantigen involved in several human autoimmune diseases. We will illustrate the different steps in structure prediction of GAD 65 by use of two experimentally determined structures of pig kidney DOPA decarboxylase (one structure in complex with the inhibitor carbidopa) as templates. The resulting model of GAD 65 provides detailed information about the active site of the protein and selected epitopes. By analysis of the interactions between the DOPA decarboxylase with the inhibitor carbidopa, the residues of the GAD 65 active site can be identified via the sequence alignment between DOPA and GAD 65. The locations of known epitopes in the molecule are visualized in special representations giving insights into mechanisms of antigenicity. Hydrophobicity analysis gives first hints for the adherence ability of GAD 65 to the cell membrane. Homology modelling is at present one of the most efficient techniques to provide accurate structural models of proteins. It is expected that in few years, for every new determined protein sequence, at least one member with a known structure of the same protein family will be available, which will steadily increase the importance and applicability of homology modelling.
- 1 February 2007
- Published by Walter de Gruyter GmbH in Pteridines
- Vol. 18 (1) , 79-94
Open AccessA Basic Molecular Analysis of the Diabetic Antigen GAD by Homology Modelling. Principles of the Method and Understanding of Antigenicity and Binding Sites
Functional specificity of a protein is linked to its structure. A growing section of bioinformatics deals with the prediction and visualization of protein 3D structures. In homology modelling, a protein sequence with an unknown structure is aligned with sequences of known protein structures. By exploiting structural information from the known configurations, the new structure can be predicted. In this introductory paper, we will present the principles of homology modelling and demonstrate the method used, by determining the structure of the enzyme glutamic decarboxylase (GAD 65). This protein is an autoantigen involved in several human autoimmune diseases. We will illustrate the different steps in structure prediction of GAD 65 by use of two experimentally determined structures of pig kidney DOPA decarboxylase (one structure in complex with the inhibitor carbidopa) as templates. The resulting model of GAD 65 provides detailed information about the active site of the protein and selected epitopes. By analysis of the interactions between the DOPA decarboxylase with the inhibitor carbidopa, the residues of the GAD 65 active site can be identified via the sequence alignment between DOPA and GAD 65. The locations of known epitopes in the molecule are visualized in special representations giving insights into mechanisms of antigenicity. Hydrophobicity analysis gives first hints for the adherence ability of GAD 65 to the cell membrane. Homology modelling is at present one of the most efficient techniques to provide accurate structural models of proteins. It is expected that in few years, for every new determined protein sequence, at least one member with a known structure of the same protein family will be available, which will steadily increase the importance and applicability of homology modelling.